This is supported by a previous study demonstrating increased expression of pyrogenic cytokines such as tumour necrosis factor-α, interleukin (IL)-1, IL-6 and interferon-gamma in the circulation and muscles in patients with inflammatory myopathies [29,30], which are also thought to be relevant for disease pathogenesis [31]. This evidence concerns the gene IL6 and myopathy.